Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Dermatol Online J ; 20(8)2014 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-25148274

RESUMO

Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma and can have a variety of clinical and histological manifestations, including erythrodermic, pustular, bullous, hypo/hyperpigmented, and verrucous forms. We describe a case of a 59-year-old woman who presented with verrucous hyperkeratotic plaques on her distal fingertips, dorsal feet, and areolae that were subsequently biopsied and shown to be mycosis fungoides. This case highlights one of the many atypical manifestations of MF and underscores the need to have a high clinical suspicion for the disease.


Assuntos
Micose Fungoide/patologia , Neoplasias Cutâneas/patologia , Biópsia , Carcinoma Verrucoso/diagnóstico , Diagnóstico Diferencial , Evolução Fatal , Feminino , , Mãos , Humanos , Pessoa de Meia-Idade
2.
Clin Dermatol ; 33(3): 300-4, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25889130

RESUMO

Squaric acid dibutylester is a topical sensitizing agent utilized for the treatment of alopecia areata. The mechanism of action is not fully understood, but is believed to redirect the inflammatory response by invoking allergic contact dermatitis. Several studies have compared the efficacy of squaric acid dibutylester to other treatments vs placebo with favorable results. This contribution reviews the history of the topical sensitizing agent squaric acid dibutylester and discusses the mechanism of action, the use in alopecia areata, and the efficacy and safety of this therapeutic agent.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Alopecia em Áreas/tratamento farmacológico , Ciclobutanos/uso terapêutico , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA